Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
5.73
Dollar change
-0.08
Percentage change
-1.38
%
IndexRUT P/E- EPS (ttm)-2.14 Insider Own58.50% Shs Outstand97.38M Perf Week-0.35%
Market Cap687.26M Forward P/E- EPS next Y-1.65 Insider Trans15.85% Shs Float49.77M Perf Month-27.74%
Income-198.13M PEG- EPS next Q-0.46 Inst Own22.37% Short Float19.94% Perf Quarter-29.69%
Sales0.00M P/S- EPS this Y22.50% Inst Trans- Short Ratio14.32 Perf Half Y-22.04%
Book/sh1.37 P/B4.19 EPS next Y2.43% ROA-52.99% Short Interest9.92M Perf Year-54.67%
Cash/sh1.01 P/C5.65 EPS next 5Y- ROE-88.19% 52W Range5.47 - 17.20 Perf YTD-35.33%
Dividend Est.- P/FCF- EPS past 5Y-193.88% ROI-144.17% 52W High-66.69% Beta1.87
Dividend TTM- Quick Ratio2.53 Sales past 5Y-25.00% Gross Margin- 52W Low4.66% ATR (14)0.47
Dividend Ex-DateSep 10, 2019 Current Ratio2.53 EPS Y/Y TTM-45.24% Oper. Margin0.00% RSI (14)34.19 Volatility5.24% 7.06%
Employees234 Debt/Eq0.10 Sales Y/Y TTM- Profit Margin- Recom1.57 Target Price15.71
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q-61.42% Payout- Rel Volume0.73 Prev Close5.81
Sales Surprise-100.00% EPS Surprise-29.50% Sales Q/Q- EarningsMar 01 BMO Avg Volume692.95K Price5.73
SMA20-12.86% SMA50-21.39% SMA200-39.04% Trades Volume509,055 Change-1.38%
Date Action Analyst Rating Change Price Target Change
Apr-08-24Initiated TD Cowen Buy
Apr-03-24Initiated Wedbush Outperform $12
Jan-16-24Downgrade Stifel Buy → Hold $18 → $9
Dec-08-23Initiated Citigroup Neutral $10
Oct-09-23Initiated BMO Capital Markets Outperform $19
Jul-31-23Initiated Guggenheim Buy $24
Apr-18-23Initiated Stifel Buy $18
Nov-14-22Initiated Morgan Stanley Equal-Weight $23
Nov-14-22Initiated JP Morgan Overweight $27
Nov-14-22Initiated Jefferies Buy $25
Mar-27-24 08:45AM
Mar-14-24 02:44PM
Mar-01-24 02:00PM
08:00AM
Feb-29-24 03:02AM
08:00AM Loading…
Feb-28-24 08:00AM
Feb-20-24 04:01PM
Feb-14-24 11:50PM
04:05PM
Feb-01-24 08:00AM
Jan-25-24 08:00AM
Jan-09-24 06:21PM
Jan-05-24 05:00PM
08:00AM
Jan-02-24 08:00AM
10:30AM Loading…
Dec-19-23 10:30AM
Nov-30-23 07:45AM
Nov-08-23 08:00AM
Nov-03-23 04:01PM
Oct-30-23 03:46PM
Oct-27-23 06:00AM
Oct-24-23 07:30AM
05:04AM
Oct-23-23 02:50AM
Oct-17-23 08:00AM
Oct-09-23 09:33AM
Sep-19-23 08:00AM
Aug-31-23 08:00AM
Aug-07-23 04:01PM
Jul-25-23 07:45AM
08:46AM Loading…
Jun-29-23 08:46AM
Jun-22-23 08:00AM
Jun-02-23 10:15AM
May-31-23 08:00AM
May-26-23 09:45AM
May-17-23 04:05PM
06:00AM
May-11-23 08:00AM
Mar-27-23 08:00AM
Mar-09-23 08:00AM
Feb-27-23 08:00AM
Jan-20-23 05:56AM
Jan-09-23 07:00AM
Jan-03-23 08:00AM
Nov-01-22 04:13PM
Oct-24-22 05:30PM
Oct-20-22 12:45PM
Oct-19-22 09:47PM
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARCH Venture Partners XII, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:38 PM
ARCH Venture Partners X, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:37 PM
NELSEN ROBERTDirectorFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:41 PM
GV 2019 GP, L.L.C.10% OwnerJun 21 '23Sale14.9719,003284,4960Jun 22 05:03 PM
GV 2019 GP, L.L.C.10% OwnerJun 20 '23Sale15.0637,405563,2480Jun 22 05:03 PM
GV 2019 GP, L.L.C.10% OwnerJun 16 '23Sale15.026,53298,1090Jun 20 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 15 '23Sale14.9266,659994,3260Jun 20 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 14 '23Sale14.8728,960430,6840Jun 15 04:22 PM
GV 2019 GP, L.L.C.10% OwnerJun 13 '23Sale15.1328,100425,1020Jun 15 04:22 PM
GV 2019 GP, L.L.C.10% OwnerJun 12 '23Sale14.9816,031240,1510Jun 13 04:20 PM
GV 2019 GP, L.L.C.10% OwnerJun 09 '23Sale14.4815,672226,9840Jun 13 04:20 PM
GV 2019 GP, L.L.C.10% OwnerJun 08 '23Sale15.745,00078,6860Jun 09 04:24 PM
GV 2019 GP, L.L.C.10% OwnerJun 07 '23Sale16.9215,000253,8710Jun 09 04:24 PM
GV 2019 GP, L.L.C.10% OwnerJun 06 '23Sale17.0229,975510,1660Jun 07 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 05 '23Sale16.7022,434374,6120Jun 07 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 01 '23Sale14.3645,223649,1940Jun 02 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 31 '23Sale13.6516,633227,0040Jun 02 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 30 '23Sale13.7016,805230,2400May 31 04:15 PM
GV 2019 GP, L.L.C.10% OwnerMay 26 '23Sale13.7012,602172,6030May 31 04:15 PM
GV 2019 GP, L.L.C.10% OwnerMay 25 '23Sale13.3823,161309,9730May 26 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 24 '23Sale13.667,900107,9200May 26 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 23 '23Sale14.7443,939647,6480May 24 05:07 PM
GV 2019 GP, L.L.C.10% OwnerMay 22 '23Sale14.1387,9221,242,0920May 24 05:07 PM
GV 2019 GP, L.L.C.10% OwnerMay 19 '23Sale13.8863,212877,0660May 22 04:21 PM
GV 2019 GP, L.L.C.10% OwnerMay 18 '23Sale13.0427,098353,2710May 22 04:21 PM
GV 2019 GP, L.L.C.10% OwnerMay 17 '23Sale12.7715,000191,60010,735,324May 18 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 16 '23Sale12.5950,649637,67610,750,324May 18 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 15 '23Sale12.74157,9522,012,08710,800,973May 16 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 12 '23Sale12.7227,290347,22210,958,925May 16 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 11 '23Sale13.1326,626349,53310,986,215May 12 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 10 '23Sale14.0387,3971,225,80411,012,841May 12 04:16 PM
GV 2019 GP, L.L.C.10% OwnerMay 09 '23Sale14.08321,2384,522,61311,100,238May 10 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 08 '23Sale14.13100,7721,423,72711,421,476May 10 04:17 PM